GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Other Stockholders Equity

Schott Pharma AG KGaA (WBO:1SXP) Other Stockholders Equity : €184.5 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Other Stockholders Equity?

Schott Pharma AG KGaA's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €184.5 Mil.

Schott Pharma AG KGaA's quarterly Other Stockholders Equity increased from Jun. 2024 (€122.5 Mil) to Sep. 2024 (€145.3 Mil) and increased from Sep. 2024 (€145.3 Mil) to Dec. 2024 (€184.5 Mil).

Schott Pharma AG KGaA's annual Other Stockholders Equity declined from Sep. 2022 (€707.3 Mil) to Sep. 2023 (€45.3 Mil) but then increased from Sep. 2023 (€45.3 Mil) to Sep. 2024 (€145.3 Mil).


Schott Pharma AG KGaA Other Stockholders Equity Historical Data

The historical data trend for Schott Pharma AG KGaA's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Other Stockholders Equity Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Other Stockholders Equity
314.52 417.96 707.28 45.34 145.31

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.22 80.96 122.47 145.31 184.51

Schott Pharma AG KGaA Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Schott Pharma AG KGaA Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines